Novocell uses embryonic stem cells to treat diabetes in mice

02/20/2008 | San Diego Union-Tribune ·

Scientists at San Diego-based Novocell were able to convert human embryonic stem cells into cells that secrete insulin and control diabetes in mice whose insulin-producing islet cells have been destroyed. The company plans to create a continuous pool of human embryonic stem cells ready for use in human therapies to treat people with diabetes.

View Full Article in:

San Diego Union-Tribune ·

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL